Peptide record

TPDB20136

Antibacterial Anticancer Antifungal Antiparasitic Antiviral Hemolysis Toxicity standard
30 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB20136
Antibacterial Anticancer Antifungal Antiparasitic Antiviral Hemolysis Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
Peptipedia AntiCP 2.0 iACP-DRLF Antifungipept AI4AVP dbAMP 3.0 DRAMP APD_complete APD_hemolytic Hemolytic2 ToxinPred 3.0
standard
No
A 30-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from Peptipedia, AntiCP 2.0, iACP-DRLF, and other sources, with an available 3D structural model.
Sequence
GIPCAESCVWIPCTVTALLGCSCSNNVCYN
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C131H206N34O42S6
RDQHKMF
C
3121.64
3.29
0
1
11
-1
-0.17
0.793
87.67
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
7365
2.36
15
Residue Composition
number
2
A
0
R
3
N
0
D
6
C
1
E
0
Q
2
G
0
H
2
I
2
L
0
K
0
M
0
F
2
P
3
S
2
T
1
W
1
Y
3
V
Amino Acid Distribution
A: 2 R: 0 N: 3 D: 0 C: 6 E: 1 Q: 0 G: 2 H: 0 I: 2 L: 2 K: 0 M: 0 F: 0 P: 2 S: 3 T: 2 W: 1 Y: 1 V: 3
Chemical Descriptors
30 reviewed residue count
C131H206N34O42S6 sequence-only estimate (linear, free termini)
3121.64 sequence-only estimate (linear, free termini)
3.29 sequence-only estimate (linear, free termini)
-1 sequence-only estimate (linear, free termini)
-0.17 sequence-only estimate (linear, free termini)
0.793 sequence-only estimate (linear, free termini)
Evidence Records 3 records
Evidence 1 Activity

Activity

HD50
Hemolysis
5.5 µM
[Ref.16441062] HD50=5.5 µM against human type A red blood cells.

Target

human type A red blood cells

Source & Reference

APD_complete APD_hemolytic
DRAMP4
J Mol Biol. 1999 Dec 17 294(5):1327-1336.

Other

Source Activity Label Source Definition
Hemolysis
APD_complete APD-derived hemolytic peptide annotation. APD_hemolytic APD hemolytic peptide annotation.
Evidence 2 Activity

Activity

HD50
Toxicity
5.5 µM
Hemolytic
Hemolytic_activity: [Ref.16441062] HD50=5.5 µM against human type A red blood cells.

Target

erythrocytes

Source & Reference

NA
DRAMP
J Mol Biol. 1999 Dec 17 294(5):1327-1336.
Evidence 3 Hemolysis

Activity

5.5 µM
HD50
[Ref.16441062] HD50=5.5 µM against human type A red blood cells.
Hemolysis

Target

human type A red blood cells

Source & Reference

APD_complete APD_hemolytic
J Mol Biol. 1999 Dec 17 294(5):1327-1336.
DRAMP4
APD_complete APD_hemolytic